Company intelligence
BrainGoMo
Bring neurofeedback to everyday life and improve the life quality of many patients!
About BrainGoMo
BrainGoMo revolutionizes the way neurofeedback training can be performed. We are developing a mobile neurofeedback platform, enabling patients to perform their neurofeedback training outside of clinics with the help of an innovative smartphone app, state-of-the-art hardware and an interactive webserver. At first ADHD patients will be able to benefit from our innovations, as neurofeedback is already a scientifically validated and used training for this disorder. In comparison to traditional medication neurofeedback does not have any side effects. Currently our Start-Up is based at the Institute of Biomagnetism and Biosignalanalysis at the university medical centre in Münster, while our developments are funded by the Start-Up Transfer.NRW in combination with EFRE. In case you want to get in contact with us, feel free to connect with us on LinkedIn! We are looking forward to your message.
Verified activity
Signals from BrainGoMo
2 published signals
Research & Knowledge
BrainGoMo published a study in npj Digital Medicine by researchers from University of Geneva and collaborators that examined 82 cognitively healthy adults using wearable and smartphone data to track cognitive and affective changes.
Reported by Omid Abbasi
Research & Knowledge
BrainGoMo published a preprint from DTU - Technical University of Denmark & Stanford University (led by Andreas Brink-Kjær) showing that raw wrist accelerometry from UK Biobank participants can predict 390 future diseases with a mean C-index of 0.69 and AUROC of 0.90.
Reported by Omid Abbasi